Real‐world data on cannabidiol treatment of various epilepsy subtypes: A retrospective, multicenter study
Sign Up to like & getrecommendations! Published in 2023 at "Epilepsia Open"
DOI: 10.1002/epi4.12699
Abstract: Cannabidiol (CBD) is approved for treatment of Dravet syndrome (DS), Lennox‐Gastaut syndrome (LGS), and tuberous sclerosis complex (TSC). Several studies suggest antiseizure effects also beyond these three epilepsy syndromes. read more here.
Keywords: world data; cannabidiol treatment; epilepsy; treatment ... See more keywords